Badr Al Bawardy, MD

• David N. Assis
• Deborah Proctor
• Jill Gaidos
• Kenneth Hung
• Marie Robert
• Peggy Myung
• Shawn Cowper

Colitis, Ulcerative; Crohn Disease; Inflammatory Bowel Diseases; Treatment Outcome

• Early Flexible Sigmoidoscopy Improves Clinical Outcomes in Acute Severe Ulcerative ColitisSharma S, Li D, Levine L, Chaar A, McMillan C, Gaidos J, Proctor D, Al-Bawardy B. Early Flexible Sigmoidoscopy Improves Clinical Outcomes in Acute Severe Ulcerative Colitis. Crohn's & Colitis 360 2023, 5: otad032. PMID: 37323477, PMCID: PMC10263117, DOI: 10.1093/crocol/otad032.
• Oral Vancomycin Induced and Maintained Clinical and Endoscopic Remission in Ulcerative Colitis and Primary Sclerosing Cholangitis Post-liver Transplantation.Almomen H, Al-Bawardy B. Oral Vancomycin Induced and Maintained Clinical and Endoscopic Remission in Ulcerative Colitis and Primary Sclerosing Cholangitis Post-liver Transplantation. Inflammatory Bowel Diseases 2023, 29: 837-838. PMID: 36888548, DOI: 10.1093/ibd/izad040.
• Assessment of Inflammatory Bowel Disease Training Among Gastroenterology Fellows.Al-Bawardy B, Malter L, Ehrlich A, Rieder F, Gaidos J, Proctor D, Windish D. Assessment of Inflammatory Bowel Disease Training Among Gastroenterology Fellows. Inflammatory Bowel Diseases 2023 PMID: 36810663, DOI: 10.1093/ibd/izad030.
• Outcomes of immunomodulator and advanced therapies for primary sclerosing cholangitis-associated inflammatory bowel diseaseSayed A, Assis D, Silveira M, Deng Y, Ciarleglio M, Gaidos J, Proctor D, Al-Bawardy B. Outcomes of immunomodulator and advanced therapies for primary sclerosing cholangitis-associated inflammatory bowel disease. European Journal Of Gastroenterology & Hepatology 2023, 35: 270-274. PMID: 36708297, DOI: 10.1097/meg.0000000000002510.
• Comparative Safety of Biologic Agents in Patients With Inflammatory Bowel Disease With Active or Recent Malignancy: A Multi-Center Cohort StudyHolmer A, Luo J, Russ K, Park S, Yang J, Ertem F, Dueker J, Nguyen V, Hong S, Zenger C, Axelrad J, Sofia A, Petrov J, Al-Bawardy B, Fudman D, Llano E, Dailey J, Jangi S, Khakoo N, Damas O, Barnes E, Scott F, Ungaro R, Singh S, Helping-IBD R. Comparative Safety of Biologic Agents in Patients With Inflammatory Bowel Disease With Active or Recent Malignancy: A Multi-Center Cohort Study. Clinical Gastroenterology And Hepatology 2023, 21: 1598-1606.e5. PMID: 36642291, DOI: 10.1016/j.cgh.2023.01.002.
• Therapeutic drug monitoring of ustekinumab and vedolizumab in inflammatory bowel disease: worth the draw?Chaar A, Atiyat R, Al-Bawardy B. Therapeutic drug monitoring of ustekinumab and vedolizumab in inflammatory bowel disease: worth the draw? Digestive Medicine Research 2023, 0: 0-0. DOI: 10.21037/dmr-22-80.
• Saudi Arabia consensus guidance for the diagnosis and management of adults with inflammatory bowel disease.Mosli M, Almudaiheem H, AlAmeel T, Bakkari S, Alharbi O, Alenzi K, Khardaly A, AlMolaiki M, Al-Omari B, Albarakati R, Al-Jedai A, Saadah O, Almadi M, Al-Bawardy B. Saudi Arabia consensus guidance for the diagnosis and management of adults with inflammatory bowel disease. Saudi Journal Of Gastroenterology 2022 PMID: 36412460, DOI: 10.4103/sjg.sjg_277_22.
• Open-Capsule Budesonide for the Treatment of Isolated Immune Checkpoint Inhibitor-Induced EnteritisHussain N, Robert M, Al-Bawardy B. Open-Capsule Budesonide for the Treatment of Isolated Immune Checkpoint Inhibitor-Induced Enteritis. ACG Case Reports Journal 2022, 9: e00882. PMID: 36237281, PMCID: PMC9553371, DOI: 10.14309/crj.0000000000000882.
• Gastrointestinal vascular malformations and neoplasms: arterial, venous, arteriovenous, and capillaryAl‐Bawardy B, Proctor D. Gastrointestinal vascular malformations and neoplasms: arterial, venous, arteriovenous, and capillary. 2022, 2293-2314. DOI: 10.1002/9781119600206.ch113.
• Effect of obesity on vedolizumab response in inflammatory bowel diseaseLevine LJ, Gaidos JKJ, Proctor DD, Viana AV, Al-Bawardy B. Effect of obesity on vedolizumab response in inflammatory bowel disease. Annals Of Gastroenterology 2022, 35: 275-280. PMID: 35599926, PMCID: PMC9062841, DOI: 10.20524/aog.2022.0699.
• Impact of thiopurine dose in anti-tumor necrosis factor combination therapy on outcomes in inflammatory bowel diseaseNawaz A, Glick L, Chaar A, Li D, Gaidos J, Proctor D, Al-Bawardy B. Impact of thiopurine dose in anti-tumor necrosis factor combination therapy on outcomes in inflammatory bowel disease. Annals Of Gastroenterology 2022, 36: 39-44. PMID: 36593807, PMCID: PMC9756033, DOI: 10.20524/aog.2022.0766.
• The Impact of Inflammatory Bowel Disease Clinic On-site Vaccination ServicesHussain N, Proctor D, Al-Bawardy B. The Impact of Inflammatory Bowel Disease Clinic On-site Vaccination Services. Crohn's & Colitis 360 2021, 3: otab067-. DOI: 10.1093/crocol/otab067.
• The Impact of Inflammatory Bowel Disease Clinic On-site Vaccination ServicesHussain N, Proctor D, Al-Bawardy B. The Impact of Inflammatory Bowel Disease Clinic On-site Vaccination Services. Crohn's & Colitis 360 2021, 3: otab067-. PMID: 36777277, PMCID: PMC9802036, DOI: 10.1093/crocol/otab067.
• Immune Checkpoint Inhibitor–associated Diarrhea and Colitis: A Systematic Review and Meta-analysis of Observational StudiesTran AN, Wang M, Hundt M, Chugh R, Ohm J, Grimshaw A, Ciarleglio M, Hung KW, Proctor DD, Price CC, Laine L, Al-Bawardy B. Immune Checkpoint Inhibitor–associated Diarrhea and Colitis: A Systematic Review and Meta-analysis of Observational Studies. Journal Of Immunotherapy 2021, 44: 325-334. PMID: 34380976, DOI: 10.1097/cji.0000000000000383.
• Certolizumab Trough Levels and Antibodies in Crohn’s Disease: A Single-Center ExperienceRamos G, Al-Bawardy B, Neto M, Bledsoe A, Quinn K, Heron V, Willrich M, Johnson A, Chedid V, Coelho-Prabhu N, Kisiel J, Papadakis K, Pardi D, Kane S, Tremaine W, Raffals L, Bruining D, Faubion W, Harmsen W, Loftus E. Certolizumab Trough Levels and Antibodies in Crohn’s Disease: A Single-Center Experience. Crohn's & Colitis 360 2021, 3: otab019-. DOI: 10.1093/crocol/otab019.
• Certolizumab Trough Levels and Antibodies in Crohn’s Disease: A Single-Center ExperienceRamos G, Al-Bawardy B, Neto M, Bledsoe A, Quinn K, Heron V, Willrich M, Johnson A, Chedid V, Coelho-Prabhu N, Kisiel J, Papadakis K, Pardi D, Kane S, Tremaine W, Raffals L, Bruining D, Faubion W, Harmsen W, Loftus E. Certolizumab Trough Levels and Antibodies in Crohn’s Disease: A Single-Center Experience. Crohn's & Colitis 360 2021, 3: otab019-. PMID: 36776673, PMCID: PMC9802288, DOI: 10.1093/crocol/otab019.
• Novel and Emerging Therapies for Inflammatory Bowel DiseaseAl-Bawardy B, Shivashankar R, Proctor DD. Novel and Emerging Therapies for Inflammatory Bowel Disease. Frontiers In Pharmacology 2021, 12: 651415. PMID: 33935763, PMCID: PMC8080036, DOI: 10.3389/fphar.2021.651415.
• Certolizumab Trough Levels and Antibodies in Crohn’s Disease: A Single-Center ExperiencePiovezani Ramos, G., Al-Bawardy B, M. B. B. Neto, A. C. Bledsoe, K. P. Quinn, V. Heron, M. A. V. Willrich, A. Johnson, V. G. Chedid, N. Coelho-Prabhu, J. B. Kisiel, K. A. Papadakis, D. Pardi, S. Kane, W. J. Tremaine, L. Raffals, D. H. Bruining, W. A. Faubion, W. S. Harmsen and E. V. Loftus, Jr (2021). "Certolizumab Trough Levels and Antibodies in Crohn’s Disease: A Single-Center Experience.", Crohn's & Colitis 360, Volume 3, Issue 3, July 2021, otab019,
• Cutaneous Vasculitis After Ustekinumab Induction in Crohn's Disease.Chugh R, Proctor DD, Little A, Myung P, Cowper S, Imaeda S, Pashankar DS, Al-Bawardy B. Cutaneous Vasculitis After Ustekinumab Induction in Crohn's Disease. Inflammatory Bowel Diseases 2020, 27: e30-e31. PMID: 33179735, DOI: 10.1093/ibd/izaa285.
• The Impact of Vedolizumab on Pre-Existing Extraintestinal Manifestations of Inflammatory Bowel Disease: A Multicenter Study.Ramos GP, Dimopoulos C, McDonald NM, Janssens LP, Hung KW, Proctor D, Ruggiero E, Kane S, Bruining DH, Faubion WA, Raffals LE, Loftus EV, Al-Bawardy B. The Impact of Vedolizumab on Pre-Existing Extraintestinal Manifestations of Inflammatory Bowel Disease: A Multicenter Study. Inflammatory Bowel Diseases 2020, 27: 1270-1276. PMID: 33165569, DOI: 10.1093/ibd/izaa293.
• The emerging role of Janus kinase inhibitors in the treatment of autoimmune and inflammatory diseasesDamsky W, Peterson D, Ramseier J, Al-Bawardy B, Chun H, Proctor D, Strand V, Flavell RA, King B. The emerging role of Janus kinase inhibitors in the treatment of autoimmune and inflammatory diseases. Journal Of Allergy And Clinical Immunology 2020, 147: 814-826. PMID: 33129886, DOI: 10.1016/j.jaci.2020.10.022.
• SARS-CoV-2 Infection and Dual-Biologic Therapy for Crohn’s DiseaseDimopoulos C, Al-Bawardy B. SARS-CoV-2 Infection and Dual-Biologic Therapy for Crohn’s Disease. Inflammatory Bowel Diseases 2020, 26: izaa275-. PMID: 33043966, PMCID: PMC7665493, DOI: 10.1093/ibd/izaa275.
• Upper gastrointestinal bleeding: Causes and patient outcomesAlmadi MA, Almutairdi A, Alruzug IM, Aldarsouny TA, Semaan T, Aldaher MK, AlMustafa A, Azzam N, Batwa F, Albawardy B, Aljebreen A. Upper gastrointestinal bleeding: Causes and patient outcomes. Saudi Journal Of Gastroenterology 2020, 27: 20-27. PMID: 33047678, PMCID: PMC8083248, DOI: 10.4103/sjg.sjg_297_20.
• Prospective multicenter study to evaluate capsule endoscopy competency using a validated assessment toolRajan E, Martinez M, Gorospe E, Al Bawardy B, Dobashi A, Mara KC, Hansel SL, Bruining DH, Murray JA, Leggett CL, Nehra V, Iyer PG, Pasha SF, Leighton JA, Shiff AD, Gurudu SR, Raffals LE, Lavey C, Katzka DA, Chen CH. Prospective multicenter study to evaluate capsule endoscopy competency using a validated assessment tool. Gastrointestinal Endoscopy 2019, 91: 1140-1145. PMID: 31883863, DOI: 10.1016/j.gie.2019.12.024.
• Distinct Cutoff Values of Adalimumab Trough Levels Are Associated With Different Therapeutic Outcomes in Patients with Inflammatory Bowel DiseasePark S, Al-Bawardy B, Aniwan S, Kane S, Coelho-Prabhu N, Papadakis K, Kisiel J, Bruining D, Faubion W, Raffals L, Pardi D, Tremaine W, Stephens M, Tung J, Khanna S, Willrich M, Loftus E. Distinct Cutoff Values of Adalimumab Trough Levels Are Associated With Different Therapeutic Outcomes in Patients with Inflammatory Bowel Disease. Crohn's & Colitis 360 2019, 1 DOI: 10.1093/crocol/otz047.
• The Combination of Patient-Reported Clinical Symptoms and an Endoscopic Score Correlates Well with Health-Related Quality of Life in Patients with Ulcerative ColitisAniwan S, Bruining DH, Park SH, Al-Bawardy B, Kane SV, Prabhu N, Kisiel JB, Raffals LE, Papadakis KA, Pardi DS, Tremaine WJ, Loftus EV. The Combination of Patient-Reported Clinical Symptoms and an Endoscopic Score Correlates Well with Health-Related Quality of Life in Patients with Ulcerative Colitis. Journal Of Clinical Medicine 2019, 8: 1171. PMID: 31387259, PMCID: PMC6723355, DOI: 10.3390/jcm8081171.
• Patient-oriented education and visual-aid intervention are inadequate to identify patients with potential capsule retention: a prospective randomized studyAl-Bawardy B, Kamboj AK, Desai S, Gorospe E, Bruining DH, Gostout CJ, Hansel SL, Larson MV, Murray JA, Nehra V, Leggett CL, Szarka LA, Watson RE, Rajan E. Patient-oriented education and visual-aid intervention are inadequate to identify patients with potential capsule retention: a prospective randomized study. Scandinavian Journal Of Gastroenterology 2019, 54: 662-665. PMID: 31034255, DOI: 10.1080/00365521.2019.1608465.
• Findings of CT-Derived Bone Strength Assessment in Inflammatory Bowel Disease Patients Undergoing CT Enterography in Clinical Practice.Maldonado FJ, Al Bawardy BF, Nehra AK, Lee YS, Bruining DH, Adkins MC, Keaveny TM, Johnson MP, Fidler JL, McCollough CH, Fletcher JG. Findings of CT-Derived Bone Strength Assessment in Inflammatory Bowel Disease Patients Undergoing CT Enterography in Clinical Practice. Inflammatory Bowel Diseases 2018, 25: 1072-1079. PMID: 30476314, DOI: 10.1093/ibd/izy341.
• Vedolizumab Drug Level Correlation With Clinical Remission, Biomarker Normalization, and Mucosal Healing in Inflammatory Bowel Disease.Al-Bawardy B, Ramos GP, Willrich MAV, Jenkins SM, Park SH, Aniwan S, Schoenoff SA, Bruining DH, Papadakis KA, Raffals L, Tremaine WJ, Loftus EV. Vedolizumab Drug Level Correlation With Clinical Remission, Biomarker Normalization, and Mucosal Healing in Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2018, 25: 580-586. PMID: 30165638, DOI: 10.1093/ibd/izy272.
• Danazol treatment of gastrointestinal bleeding in left ventricular assist device-supported patients.Schettle S, Bawardy BA, Asleh R, Sherazi S, Rajan E, Stulak J, Pereira N. Danazol treatment of gastrointestinal bleeding in left ventricular assist device-supported patients. The Journal Of Heart And Lung Transplantation : The Official Publication Of The International Society For Heart Transplantation 2018, 37: 1035-1037. PMID: 29907501, DOI: 10.1016/j.healun.2018.04.013.
• Outcomes of repeat balloon assisted enteroscopy in small-bowel bleedingAl-Bawardy B, Ramos G, Lennon R, Gorospe E, Song L, Bruining D, Alexander J, Coelho-Prabhu N, Fidler J, Rajan E. Outcomes of repeat balloon assisted enteroscopy in small-bowel bleeding. Endoscopy International Open 2018, 06: e694-e699. PMID: 29868634, PMCID: PMC5979197, DOI: 10.1055/a-0599-6085.
• Outcomes of Treatment for Latent Tuberculosis Infection in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy.Ramos GP, Stroh G, Al-Bawardy B, Faubion WA, Papadakis KA, Escalante P. Outcomes of Treatment for Latent Tuberculosis Infection in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy. Inflammatory Bowel Diseases 2018, 24: 2272-2277. PMID: 29718223, DOI: 10.1093/ibd/izy133.
• Outcomes of endoscopic intervention for overt GI bleeding in severe thrombocytopeniaRamos GP, Binder M, Hampel P, Braga Neto MB, Sunjaya D, Al Bawardy B, Abu Dayyeh BK, Buttar NS, Bruining DH, Prabhu-Coelho N, Larson MV, Wong Kee Song LM, Rajan E. Outcomes of endoscopic intervention for overt GI bleeding in severe thrombocytopenia. Gastrointestinal Endoscopy 2018, 88: 55-61. PMID: 29408558, DOI: 10.1016/j.gie.2018.01.028.
• Uncommon Cause of Abdominal Pain, Nausea, and VomitingAl-Bawardy B, Hansel SL. Uncommon Cause of Abdominal Pain, Nausea, and Vomiting. Clinical Gastroenterology And Hepatology 2018, 17: e21. PMID: 29360508, DOI: 10.1016/j.cgh.2018.01.015.
• Small bowel bleeding in patients with left ventricular assist device: outcomes of conservative therapy versus balloon-assisted enteroscopyAl-Bawardy B, Schettle SD, Gorospe E, Song L, Pereira NL, Alexander JA, Bruining DH, Coelho-Prabhu N, Fidler JL, Mauermann WJ, Barbara DW, Dierkhising R, Rajan E. Small bowel bleeding in patients with left ventricular assist device: outcomes of conservative therapy versus balloon-assisted enteroscopy. Annals Of Gastroenterology 2018, 31: 692-697. PMID: 30386119, PMCID: PMC6191869, DOI: 10.20524/aog.2018.0316.
• Response:Al-Bawardy B, Rajan E, Wong Kee Song LM. Response:. Gastrointestinal Endoscopy 2017, 86: 750-751. PMID: 28917355, DOI: 10.1016/j.gie.2017.06.006.
• Endoscopic and Radiographic Assessment of Crohn's DiseaseAl-Bawardy B, Hansel SL, Fidler JL, Barlow JM, Bruining DH. Endoscopic and Radiographic Assessment of Crohn's Disease. Gastroenterology Clinics Of North America 2017, 46: 493-513. PMID: 28838411, DOI: 10.1016/j.gtc.2017.05.005.
• Endoscopic muscle biopsy sampling of the duodenum and rectum: a pilot survival study in a porcine model to detect myenteric neuronsRajan E, Al-Bawardy B, Gostout CJ, Wong Kee Song LM, Deters JL, Knipschield MA, Bernard CE, Farrugia G. Endoscopic muscle biopsy sampling of the duodenum and rectum: a pilot survival study in a porcine model to detect myenteric neurons. Gastrointestinal Endoscopy 2017, 87: 600-606. PMID: 28734992, PMCID: PMC5775930, DOI: 10.1016/j.gie.2017.07.023.
• Late-Onset Biallelic Mismatch Repair Deficiency SyndromeEbner DW, Al-Bawardy B, Sweetser S. Late-Onset Biallelic Mismatch Repair Deficiency Syndrome. Clinical Gastroenterology And Hepatology 2017, 16: e31-e32. PMID: 28602968, DOI: 10.1016/j.cgh.2017.05.039.
• Abnormal Liver Tests and Persistent Lactic Acidosis in an 18-Year-Old WomanMalikowski T, Al-Bawardy B, Oxentenko AS. Abnormal Liver Tests and Persistent Lactic Acidosis in an 18-Year-Old Woman. Gastroenterology 2017, 152: 947-949. PMID: 28259720, DOI: 10.1053/j.gastro.2016.11.008.
• Beyond moulage sign and TTG levels: the role of cross-sectional imaging in celiac sprueSheedy SP, Barlow JM, Fletcher JG, Smyrk TC, Scholz FJ, Codipilly DC, Al Bawardy BF, Fidler JL. Beyond moulage sign and TTG levels: the role of cross-sectional imaging in celiac sprue. Abdominal Radiology 2017, 42: 361-388. PMID: 28154909, DOI: 10.1007/s00261-016-1006-2.
• Cross-sectional imaging in refractory celiac diseaseAl-Bawardy B, Barlow JM, Vasconcelos RN, Kim ST, Bruining DH, Hansel SL, Sheedy SP, Murray JA, Rubio-Tapia A, Rajan E, Fidler JL, Fletcher JG. Cross-sectional imaging in refractory celiac disease. Abdominal Radiology 2017, 42: 389-395. PMID: 28084545, DOI: 10.1007/s00261-016-1032-0.
• Celiac disease: a clinical reviewAl-Bawardy B, Codipilly DC, Rubio-Tapia A, Bruining DH, Hansel SL, Murray JA. Celiac disease: a clinical review. Abdominal Radiology 2017, 42: 351-360. PMID: 28078381, DOI: 10.1007/s00261-016-1034-y.
• Collagenous sprue cross-sectional imaging: a comparative blinded studyAl-Bawardy B, Sheedy SP, Herberts MB, Murray JA, Rubio-Tapia A, Rajan E, Bruining DH, Hansel SL, Barlow JM, Fletcher JG, Fidler JL. Collagenous sprue cross-sectional imaging: a comparative blinded study. Abdominal Radiology 2017, 42: 396-402. PMID: 28058450, DOI: 10.1007/s00261-016-1007-1.
• Inflammatory bowel disease: Clinical screening and transition of careAl-Bawardy B. Inflammatory bowel disease: Clinical screening and transition of care. Saudi Journal Of Gastroenterology 2017, 23: 213-215. PMID: 28721973, PMCID: PMC5539673, DOI: 10.4103/sjg.sjg_294_17.
• Over-the-scope clip-assisted endoscopic full-thickness resection of epithelial and subepithelial GI lesionsAl-Bawardy B, Rajan E, Wong Kee Song LM. Over-the-scope clip-assisted endoscopic full-thickness resection of epithelial and subepithelial GI lesions. Gastrointestinal Endoscopy 2016, 85: 1087-1092. PMID: 27569858, DOI: 10.1016/j.gie.2016.08.019.
• Outcomes and Predictors of Rebleeding After 2-Octyl Cyanoacrylate Injection in Acute Gastric Variceal HemorrhageAl-Bawardy B, Gorospe EC, Saleem A, Buttar NS, Song L. Outcomes and Predictors of Rebleeding After 2-Octyl Cyanoacrylate Injection in Acute Gastric Variceal Hemorrhage. Journal Of Clinical Gastroenterology 2016, 50: 458-463. PMID: 26890326, DOI: 10.1097/mcg.0000000000000487.
• Reply toAl-Bawardy B, Fletcher JG, Rajan E, Hansel SL. Reply to. Inflammatory Bowel Diseases 2016, 22: e14-e15. PMID: 26978728, DOI: 10.1097/mib.0000000000000762.
• Outcomes of double-balloon enteroscopy-assisted direct percutaneous endoscopic jejunostomy tube placementAl-Bawardy B, Gorospe EC, Alexander JA, Bruining DH, Coelho-Prabhu N, Rajan E, Wong Kee Song LM. Outcomes of double-balloon enteroscopy-assisted direct percutaneous endoscopic jejunostomy tube placement. Endoscopy 2016, 48: 552-556. PMID: 26964079, DOI: 10.1055/s-0042-101853.
• Cronkhite–Canada SyndromeCotter T, Al Bawardy B, Sweetser S. Cronkhite–Canada Syndrome. 2016, 101-116. DOI: 10.1007/978-3-319-28103-2_8.
• Diarrhea and Weight Loss in a 67-Year-Old ManAl-Bawardy B, Sweetser S. Diarrhea and Weight Loss in a 67-Year-Old Man. Gastroenterology 2015, 149: 1693-1694. PMID: 26480884, DOI: 10.1053/j.gastro.2015.08.057.
• Retained Capsule Endoscopy in a Large Tertiary Care Academic Practice and Radiologic Predictors of RetentionAl-Bawardy B, Locke G, Huprich JE, Fletcher JG, Fidler JL, Barlow JM, Becker B, Rajan E, Loftus EV, Bruining DH, Hansel SL. Retained Capsule Endoscopy in a Large Tertiary Care Academic Practice and Radiologic Predictors of Retention. Inflammatory Bowel Diseases 2015, 21: 2158-2164. PMID: 26284295, DOI: 10.1097/mib.0000000000000482.
• Lack of health insurance limits the benefits of hepatitis C virus screening: insights from the National Health and Nutrition Examination Hepatitis C follow-up study.Ditah I, Al Bawardy B, Gonzalez HC, Saberi B, Ditah C, Kamath PS, Charlton M. Lack of health insurance limits the benefits of hepatitis C virus screening: insights from the National Health and Nutrition Examination Hepatitis C follow-up study. The American Journal Of Gastroenterology 2015, 110: 1126-33. PMID: 25756239, DOI: 10.1038/ajg.2015.31.
• 58-Year-Old Woman With MelenaCotter TG, Al-Bawardy B, Loftus CG. 58-Year-Old Woman With Melena. Mayo Clinic Proceedings 2015, 90: e83-e87. PMID: 26250736, DOI: 10.1016/j.mayocp.2015.01.026.
• An Elderly Woman With an Uncommon Cause of DysphagiaAl-Bawardy B, Said SM, Iyer P. An Elderly Woman With an Uncommon Cause of Dysphagia. Gastroenterology 2015, 149: e9-e10. PMID: 26226586, DOI: 10.1053/j.gastro.2014.12.052.
• A Rare Case of Rapid Patency Capsule DisintegrationAl-Bawardy B, Rajan E, Hansel S. A Rare Case of Rapid Patency Capsule Disintegration. The American Journal Of Gastroenterology 2015, 110: 603. PMID: 25853206, DOI: 10.1038/ajg.2015.25.
• 62-Year-Old Man With Persistent Postoperative Nausea and VomitingAl Bawardy BF, Simonetto DA, Drake MT. 62-Year-Old Man With Persistent Postoperative Nausea and Vomiting. Mayo Clinic Proceedings 2015, 90: 280-283. PMID: 25659244, DOI: 10.1016/j.mayocp.2014.06.023.
• Transjugular intrahepatic portosystemic stent shunt for medically refractory hepatic hydrothorax: A systematic review and cumulative meta-analysisDitah IC, Al Bawardy BF, Saberi B, Ditah C, Kamath PS. Transjugular intrahepatic portosystemic stent shunt for medically refractory hepatic hydrothorax: A systematic review and cumulative meta-analysis. World Journal Of Hepatology 2015, 7: 1797-1806. PMID: 26167253, PMCID: PMC4491909, DOI: 10.4254/wjh.v7.i13.1797.
• Successful closure of a Billroth II duodenal stump leak with fistulization to the colon by use of stacked over-the-scope clipsGorospe EC, Desai S, Al-Bawardy B, Baron TH, Wong Kee Song LM. Successful closure of a Billroth II duodenal stump leak with fistulization to the colon by use of stacked over-the-scope clips. Gastrointestinal Endoscopy 2014, 80: 523-524. PMID: 25028277, DOI: 10.1016/j.gie.2014.06.012.
• Comparative Effectiveness of Telaprevir-Based Triple Therapy in Patients With Chronic Hepatitis CAl-Bawardy B, Kim WR, Poterucha JJ, Gross JB, Charlton MR, Larson JJ, Colby CL, Canterbury K, Warner J, Therneau TM. Comparative Effectiveness of Telaprevir-Based Triple Therapy in Patients With Chronic Hepatitis C. Mayo Clinic Proceedings 2014, 89: 595-601. PMID: 24661475, PMCID: PMC4160303, DOI: 10.1016/j.mayocp.2014.01.024.
• Recurrent bilateral pleural effusions without ascites as an initial presentation of Budd-Chiari syndrome.Desai SK, Al-Bawardy BF, Leggett C, Gorospe EC. Recurrent bilateral pleural effusions without ascites as an initial presentation of Budd-Chiari syndrome. Annals Of Gastroenterology 2014, 27: 74. PMID: 24714596, PMCID: PMC3959542.
• Malignant mesothelioma presenting as dysphagia diagnosed by endoscopic ultrasound.Al-Bawardy B, Gorospe EC, Leggett C. Malignant mesothelioma presenting as dysphagia diagnosed by endoscopic ultrasound. Annals Of Gastroenterology 2014, 27: 409. PMID: 25331960, PMCID: PMC4188942.
• Over-the-scope clip closure of pancreaticocolonic fistula caused by severe necrotizing pancreatitisGorospe EC, Desai S, Al-Bawardy B, Baron TH, Buttar NS, Wong Kee Song LM. Over-the-scope clip closure of pancreaticocolonic fistula caused by severe necrotizing pancreatitis. Gastrointestinal Endoscopy 2013, 79: 713. PMID: 24332403, DOI: 10.1016/j.gie.2013.10.042.
• Missing cohort: Inflammatory bowel disease patients at increased risk for cervical dysplasia may be undervaccinated for HPVAl‐Bawardy B, Fine S, LaFond J, Doran A, Borum ML. Missing cohort: Inflammatory bowel disease patients at increased risk for cervical dysplasia may be undervaccinated for HPV. Inflammatory Bowel Diseases 2011, 18: 797-797. PMID: 22180343, DOI: 10.1002/ibd.21660.
• Women with inflammatory bowel disease do not receive adequate cervical cancer screening or pregnancy counselingGreywoode R, LaFond J, Fine S, Al‐Bawardy B, Jencks D, Shafa S, Borum ML. Women with inflammatory bowel disease do not receive adequate cervical cancer screening or pregnancy counseling. Inflammatory Bowel Diseases 2011, 19: e6-7. PMID: 22109963, DOI: 10.1002/ibd.22836.
• Hospitalization Rates Differ in African Americans and Whites With Inflammatory Bowel DiseaseBorum M, LaFond J, Al-Bawardy B, Fine S, Sardana N. Hospitalization Rates Differ in African Americans and Whites With Inflammatory Bowel Disease. Journal Of The National Medical Association 2011, 103: 986. PMID: 22364070, DOI: 10.1016/s0027-9684(15)30457-0.